At-Home Transvaginal Ultrasound Feasible, Preferred by Some

Most patients successfully performed their own transvaginal pelvic ultrasounds at home and expressed a preference for this method over in-clinic ultrasonography, according to a nonrandomized clinical trial. The study, published in JAMA Network Open, involved 72 participants who were provided with a portable ultrasound device and instructed on its use. Researchers aimed to assess the feasibility and patient acceptance of self-administered transvaginal ultrasounds for gynecological imaging.

The trial revealed that 93% of participants were able to obtain a technically adequate image of their pelvic organs using the at-home device. This high success rate suggests that with proper training and equipment, patients can reliably conduct these examinations independently. The study also highlighted significant patient satisfaction, with 68% of participants reporting that they preferred the at-home ultrasound experience. Factors contributing to this preference included increased privacy, comfort, and convenience compared to traditional clinic visits.

Participants cited reduced waiting times and the ability to schedule the ultrasound at a time that suited them as key advantages. The at-home ultrasound was also found to be a valuable tool for monitoring conditions such as ovarian cysts and uterine fibroids, with the study noting that the images obtained were comparable in diagnostic quality to those performed by trained sonographers in a clinical setting. This could potentially reduce the burden on healthcare facilities and improve access to diagnostic imaging, particularly for individuals in remote areas or those with mobility issues.

While the findings are promising, the researchers emphasized that further studies are needed to confirm these results in larger and more diverse populations. They also noted the importance of ensuring adequate patient education and support to maintain the quality and safety of at-home ultrasounds. The study was conducted by researchers from the University of California, San Francisco (UCSF) and was funded by the National Institutes of Health (NIH).